Deutsche Telekom on Thursday increased its full-year guidance on the back of its recent acquisition in the US.

Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, announced today it has received a research grant ...